PMID: 8611044Jan 1, 1996Paper

Current status of phase I and phase II trials--experience in Habikino from 1988 to 1994

Gan to kagaku ryoho. Cancer & chemotherapy
N MasudaM Fukuoka

Abstract

Introduction of a new agent in the treatment for cancer will require usually three phases of investigation. A new drug will be tested in a small series of patients for toxicity and feasibility; the main objective of a phase I trial is to determine the maximum tolerated dose with a specific type of administration. Demonstration of activity is the major goal of phase II trials, which will place some confidence interval on the efficacy of the new agent. Information obtained from phase I and II studies should be the basis for phase III trials. Based upon our experience with the clinical development of CPT-11, this paper reviews the two factors which influence the quality of the phase I and II trials. Firstly, adequately designed and prepared plans for every clinical trial are essential minimum requirement. Another issue which has been frequently overlooked has been variation from the planned protocol treatment. Such variations can be due to the intolerance of the patient to toxicity as well as the individual physician's poor perceptions and the physician's intolerance of toxicity.

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.